Skip to main content
. Author manuscript; available in PMC: 2016 Sep 13.
Published in final edited form as: J Urol. 2010 Nov 12;185(1):104–110. doi: 10.1016/j.juro.2010.08.088

Table 4.

Trend analysis by Gleason score

Gleason 5 Gleason 6 Gleason 7 Gleason 8 Gleason 9 p Value
(difference)*
p Value
(trend)

No. Cases 6 142 52 9 8
freePSA (ng/ml):
  Mean (SD) 0.7 (0.2) 0.7 (0.5) 0.9 (0.7) 3.1 (3.8) 1.7 (2.2) 0.131 <0.001
  Median (Q1, Q3) 0.7 (0.6, 0.9) 0.6 (0.5, 0.9) 0.8 (0.5, 1.1) 0.8 (0.6, 6.1) 0.9 (0.5, 1.9)
[−2]proPSA (pg/ml):
  Mean (SD) 12.9 (2.9) 12.8 (7.8) 18.2 (16.2) 93.7 (145.5) 39.6 (49.1) 0.002 <0.001
  Median (Q1, Q3) 13.2 (10.1, 15.5) 11.1 (7.5, 16.7) 14.9 (10.1, 20.3) 19 (11, 130.3) 24.8 (12.4, 41.4)
phi:
  Mean (SD) 33.9 (9.4) 33.5 (16.4) 52.2 (49) 113.8 (149.1) 89.8 (71.4) <0.001 <0.001
  Median (Q1, Q3) 31.5 (27.9, 33.6) 29.5 (22.2, 40) 37.5 (27.9, 61.6) 50.3 (39.1, 106.4) 52.3 (38.8, 146.8)
%freePSA:
  Mean (SD) 22 (7.3) 23.3 (12.1) 18.8 (11) 17.5 (5.6) 13.7 (9.5) 0.006 <0.001
  Median (Q1, Q3) 21.8 (16, 28.2) 20 (14.8, 29.1) 16 (9.8, 24.6) 16.2 (15.5, 17.4) 11.1 (7.7, 16.1)
%[−2]proPSA:
  Mean (SD) 1.9 (0.7) 1.8 (0.7) 2.1 (0.9) 2.8 (1.9) 2.6 (1.3) 0.113 0.002
  Median (Q1, Q3) 1.6 (1.5, 2) 1.8 (1.4, 2.1) 1.9 (1.5, 2.5) 2.1 (2, 2.7) 2.2 (1.6, 3.4)
DKK1 (ng/ml):
  Mean (SD) 1.07 (0.49) 1.18 (0.6) 1.17 (0.98) 1.24 (0.45) 1.62 (1.24) 0.57 0.544
  Median (Q1, Q3) 1.05 (0.95, 1.13) 1.16 (0.76, 1.44) 0.96 (0.67, 1.35) 1.11 (0.89, 1.58) 1.09 (0.83, 2.18)
NEM (ng/ml):
  Mean (SD) 0.21 (0.23) 0.95 (4.08) 1.33 (3.3) 5.31 (10.97) 0.22 (0.2) 0.486 0.372
  Median (Q1, Q3) 0.08 (0.07, 0.37) 0.18 (0.06, 0.64) 0.15 (0.05, 0.61) 0.57 (0.12, 1.15) 0.13 (0.07, 0.39)
*

Test of difference among Gleason score categories using the Kruskal-Wallis test.

Test of linear trend of log transformed markers across Gleason score categories.